GV20 Therapeutics
bioxbh.comLocations
Shanghai, China
industry
Biotechnology · Data and Analytics · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2016
GV20 Therapeutics is a cancer immunology drug discovery and development company that uses high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets and discover and develop effective antibody drugs. The proprietary antibody drug discovery engine developed by GV20 Therapeutics contributes to the development of a strong portfolio of immuno-oncology antibody drug candidates against novel and difficult targets.
Something looks off?Open jobs at GV20 Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.